A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
- Evaluated articles (Rapid Reviews Infectious Diseases)
Abstract
Article activity feed
-
Anthony Fehr
Reviewer 1: "A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2"
Reviewer: Anthony Fehr (University of Kansas) | 📗📗📗📗◻️
-
Anthony Fehr
Review of "A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2"
Reviewer: Anthony Fehr (University of Kansas) | 📗📗📗📗◻️
-
-
SciScore for 10.1101/2020.09.11.294330: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Antibodies: Anti-β-actin antibody (Sigma; A1978) was used at 1:5000 dilution; Anti-HA antibody (CST; 37243) was used at 1:000 dilution; Anti-GFP antibody (Santa Cruz;sc-9996) was used at 1:1000 dilution; Anti-ZAPL antibody (Proteintech; 16820-1-AP) was used at 1:1000 dilution; Anti-N antibody(GeneTex; GTX632269) was used at 1:500 dilution; Goat-anti-mouse IRDye 800CW secondary antibody (licor; 926-32210) was used at 1:10,000 dilution. Anti-β-actinsuggested:…SciScore for 10.1101/2020.09.11.294330: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Antibodies: Anti-β-actin antibody (Sigma; A1978) was used at 1:5000 dilution; Anti-HA antibody (CST; 37243) was used at 1:000 dilution; Anti-GFP antibody (Santa Cruz;sc-9996) was used at 1:1000 dilution; Anti-ZAPL antibody (Proteintech; 16820-1-AP) was used at 1:1000 dilution; Anti-N antibody(GeneTex; GTX632269) was used at 1:500 dilution; Goat-anti-mouse IRDye 800CW secondary antibody (licor; 926-32210) was used at 1:10,000 dilution. Anti-β-actinsuggested: NoneAnti-HAsuggested: (Rockland Cat# 600-431-384, RRID:AB_218003)Anti-GFPsuggested: (Santa Cruz Biotechnology Cat# sc-9996, RRID:AB_627695)Anti-ZAPLsuggested: NoneAnti-N antibody(GeneTex; GTX632269suggested: NoneExperimental Models: Cell Lines Sentences Resources Cell lines: The human hepatoma cells Huh 7, baby hamster kidney cells BKH-21, Vero E6 cells were purchased from the Cell Bank of the Chinese Academy of Sciences (www.cellbank.org.cn) and routinely maintained in Dulbecco’s modified medium supplemented with 10 % FBS (Gibco) and 25 mM HEPES (Gibco). Vero E6suggested: RRID:CVCL_XD71)Huh7-GFP, Huh7-N, Huh7-ZAPL cell line was routinely maintained in the medium supplemented with 0.5 μg/ml blasticidin. Huh7-ZAPLsuggested: NoneLentivirus pseudoparticle: VSV-G-pseudotyped lentiviral particles were prepared by co-transfection of VSV-G, HIV gag-pol and lentiviral provirus plasmids into HEK293T cells. HEK293Tsuggested: NCBI_Iran Cat# C498, RRID:CVCL_0063)Experimental Models: Organisms/Strains Sentences Resources Huh7-GFP, Huh7-N, Huh7-ZAPL cell line was routinely maintained in the medium supplemented with 0.5 μg/ml blasticidin. Huh7-GFPsuggested: NoneResults from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-